Background: One of the most serious and lethal types of cancer among women with a high mortality rate is breast cancer. Relatively, this study examined the alternations of polymorphism of XRCC1gene in people with breast cancer. Methods: The alternations of polymorphism of XRCC1gene in the codon of Arg 399 Gln on 150 patients who had breast cancer and 150 normal ones as control cases in ages between 25 to 35 and also 45 to 55 after obtaining patients consent alongside with confirmation of pathology and oncology department in Imam Sajad hospital, Ramsar. Correspondingly, the genetic analysis was accomplished by RFLP-PCR technique and also MSPI restricted enzyme was used in order to find the SNPs. Results: The measured clinical qualifications of all patients were comprised: SD and Mean of age: 4.8 and 48, SD and Mean of menstrual age: 4.8 and 13, SD and mean of menopause: 4.8,49, SD and mean of height: 12 and 175, SD and mean of weight: 67.2 and 91, SD and mean of children's numbers: 103 and 3.
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INTRODUCTION:
Breast cancer is one of the most common and considerable kinds of cancer among women. 1, 2 In this way, it can be considered that breast cancer like others types is a heterogeneous disease and also besides that, environmental factors alongside with genetically factors like polymorphism are involved in carcinogenesis.
3, 4 Correspondingly, the fluctuations and modifications of many genes like XRCC1 are related directly to breast cancer. 5 Many evidence recommended that DNA damage if miss-repaired or even not repaired, may lead to alterations of genomic instability, cell death or also cancer progression.
6,7
In this account, XRCC1 gene encodes the main protein that interacts with nicked DNA and also attends with poly adenosine diphosphate ribose (PADR) polymorphism, DNA polymerase B in order to repair the single strand DNA breaks and even DNA ligase.
8
Remarkably, this gene is polymorphic, and dozens of many variants have been recognized which comprises several nonsynonymous single nucleotide polymorphisms in the coding section. According to the many research projects, recently, the association between XRCC1 polymorphism and cancer development have been confirmed.
9
In the present study, the polymorphism of XRCC1 gene in codon 399 of 150 patients who had breast cancer, in two different age ranges (25 to 35 and 45 to 55) was investigated.
MATERIALS AND METHODS:

Sampling:
The samples were obtained from 150 women who had breast cancer after getting contest and also 150 normal cases as a control in Imam Sajad hospital (Ramsar, Iran). Considerably, all of the specimens were confirmed by pathology and oncology department of the hospital. In this way, all the clinical qualifications of the patients; age, menstrual, menopause, height, weight and also the numbers of children and others clinical qualifications were analyzed and gathered in age ranges between 25 to 35 and 45 to 55.
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DNA Extraction:
The DNA of blood samples was extracted using the DNA extraction Kit (whole blood, serum, and plasma, Sina colon Co, Iran).
Quantitative and Qualitative measurements of extracted DNA:
Qualitative measurement:
In order to assure the quality of the extracted DNA, 3 L of extracted DNA of each sample was electrophoresed on agarose gel %1. After observing the special band alongside with DNA size marker, we continued the next process.
Quantitative measurement:
After analyzing the quality of the extracted DNA, 1 ng of each sample was analyzed by spectrophotometer (Eppendorf, Germany) at the 260-280 nm wavelengths.
The quantities of the extracted DNA of all samples are presented in table 1.
Primer design:
XRCC1 gene (NG-033799-NCBI), primers (Forward and Reverse) were designed using Oligo 7.0 software (table 2) .
Correspondingly, the selected region of SNP 399 was employed for amplification (table 3) .
PCR:
PCR reaction was done using a thermocycler PCR set (Eppendorf, Germany). Relatively, the PCR cycling program was fallowed as picture 1. Considerably, after PCR reaction, the PCR product was controlled qualitatively, by using electrophoresis on agarose gel 1%.
PCR-RLFP, restriction enzyme:
In order to investigate the polymorphism of XRCC1 gene in codon 399, the RLFP technique was employed, with using MSPI restriction enzyme. In this account, 10 L of PCR product, 48ML distilled water, 2L Buffer tango 10X and 2L MSPI enzyme were used. Noticeably, the protocol was fallowed carefully and finally the product was electrophoresed on agarose gel 3%.
Statistical analysis:
Standard Chi-square and Regression logistic test were employed alongside with using SPSS software (version 7, 2014). Statistical significance was considered at p < 0.05.
RESULTS:
Results of PCR products of qualitative analysis:
After using PCR RFLP with MSPI restriction enzyme on PCR product in order to investigate the SNP319 of XRCC1 genes, these results have obtained (picture 2).
The acquired bands of MSPI restriction enzyme on PCR product in order to include 136bp, 233bp, and 369bp. In this way, the results of restriction enzymes are shown in picture 3.
The numbers of acquired affected bands by restriction enzymes in normal and patients samples include:
Normal: 9 normal homozygous individual (6%), 53 homozygous individuals (33. 35%) and 88 heterozygous individuals (67.58%). In this account, the patient's samples include; 41 homozygous individuals (33.27%) and 109 heterozygous individuals (67.72%). In this way, the p-value for polymorphism of codon 319 XRCC1 gene in both normal and patients individuals was meaningful (normal, p = 0.02) and patients (p < 0.05). Notably, the confidence interval (1.52) shows that the patient's group 
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DISCUSSION
Cancer is a heterogeneous disease which is affected by genetics alteration and also environmental factors.
10, 11 Relatively, the polymorphisms of SNPs which are the causes of genetic diversity is a determining factor between the individuals and remarkably they are involved in sensitivity in cancer progression and many other diseases.
12,13
There are 4 different DNA repairing pathways in the body which more than 70 genes are active in this way.
14,15 XRCC1 gene is one the DNA repairing gene which in this repairing pathway participates removing BER and every modification in this gene can cause notable damage.
16, 17 In this way, in our study, the relationship between the polymorphism of codon Gln Arg 399 in XRCC1 gene in different ages was investigated.
Remarkably, the results of two different age ranges, 25-35 and 45-55 indicated a different conclusion. Correspondingly, in age ranges 25-35 Table 5 The numbers of created bands by restriction enzyme for normal and patient individuals.
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the incidences of cancer progression was lower than the age ranges 45-55. Notably, cancer development is increased in age 45, and approximately it is reduced after 75 years old. Relatively, the results in our research in polymorphism of XRCC1 (codon 399) on 150 patient and 150 normal cases include 35.33% homozygosity and 58.67% heterozygosity in normal cases while these results were different in patients samples as 27.33% homozygosity and 72.67% heterozygosity. Analyzing these results show that the patients samples have more probity for having heterozygosity genotype.
In comparison with results of another project, there was no meaningful correlation in polymorphism of XRCC1 gene in codon 399, while we found this correlation in our findings. 18 In a similar study by costa in XRCC1 gene codon 399, the association between the incidences of breast cancer was reported.
19 Costa found that women with genotype Arg 399 Gln are more resistant to breast cancer and these results are confirmed our projects conclusions. Another study that was done on 220 menopause women who had breast cancer and 220 normal cases indicated that the polymorphism of XRCC1 gene in codon 399 (heterozygote Gln/Gln) caused the increase of incidence of breast cancer.
20
Relatively, the results of another research which was done on 91 cancerous and 91 normal samples exactly showed that the incidence risk of people with genotype Arg/Arg and Gln/Gln is higher than people with genotype Arg/Gln in breast cancer.
21
Conclusively, our understanding of many different aspects of cancer pathobiology has been improved through the employment of molecular genetics. These findings and results have indicated that polymorphism plays an impressive and conspicuous role in many disorders particularly cancer development and also response to therapy potentially, SNPs have a notable ability in anticipating patients risk factor for cancer therapy. Conspicuously, the purity of extracted nucleic acids is really impressive in order to have better results
22,23
and also a compatible and suitable primer designing is very important and indispensable.
24
CONCLUSION
The final results have indicated that the polymorphism of XRCC1 gene in 150 patients which had breast cancer had 76.67% heterozygosity and 27.87% homozygosity.
Meanwhile, the probability of patients group with heterozygote genotype (Arg/Gln) is higher than the homozygosity. 
